跳至主要内容
临床试验/NCT01213277
NCT01213277暂停不适用

Differences in Hemoglobin Glycation Rate in Diabete Mellitus Patients

Endocrine Research Society0 个研究点目标入组 25 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
入组人数
25
主要终点
Primary endpoint is to see whether they are fast glycators

研究概览

简要总结

HbA1c is used as a gold standard to see whether patients have optimal glycemic control. Today, many physicians rely solely on HbA1c to change medication. However, there is a select group of patients that have low average glucose levels but high HbA1c levels. The investigators believe that these patients are fast glycators meaning that they incorporate sugar into their hemoglobin faster than normal. The investigators want to determine whether these patients are fast glycators.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
25 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with diabetes
  • Patients who test their sugar levels at least 3 times daily
  • Recorded diary of sugar levels for the past month
  • Willingness to have blood drawn
  • Willingness to allow their blood sugar diary to be photocopied
  • Estimated average glucose as derived from A1c is ≥ 4 mmol from measured glucose from self-monitoring blood glucose testing

排除标准

  • Patient with medical conditions that may affect their study participation or results will be excluded.
  • Patients who are anemic
  • Renal insufficient with a serum creatinine level > 200 μmol/L

结局指标

主要结局

Primary endpoint is to see whether they are fast glycators

时间窗: One Week

次要结局

  • A secondary endpoint includes adverse events such as unplanned hospitalizations for any cause that last more than 24 hours(One Week)

研究者

申办方类型
Other

相似试验